Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
2.
Malar J ; 9 Suppl 3: S3, 2010 Dec 13.
Article in English | MEDLINE | ID: mdl-21144083

ABSTRACT

Malaria mosquito research in Africa as elsewhere is just over a century old. Early trials for development of mosquito control tools were driven by colonial enterprises and war efforts; they were, therefore, tested in military or colonial settings. The failure of those tools and environmental concerns, coupled with the desperate need for integrated malaria control strategies, has necessitated the development of new malaria mosquito control tools, which are to be tested on humans, their environment and mosquito habitats. Ethical concerns start with phase 2 trials, which pose limited ethical dilemmas. Phase 3 trials, which are undertaken on vulnerable civilian populations, pose ethical dilemmas ranging from individual to community concerns. It is argued that such trials must abide by established ethical principles especially safety, which is mainly enshrined in the principle of non-maleficence. As there is total lack of experience with many of the promising candidate tools (eg genetically modified mosquitoes, entomopathogenic fungi, and biocontrol agents), great caution must be exercised before they are introduced in the field. Since malaria vector trials, especially phase 3 are intrusive and in large populations, individual and community respect is mandatory, and must give great priority to community engagement. It is concluded that new tools must be safe, beneficial, efficacious, effective, and acceptable to large populations in the short and long-term, and that research benefits should be equitably distributed to all who bear the brunt of the research burdens. It is further concluded that individual and institutional capacity strengthening should be provided, in order to undertake essential research, carry out scientific and ethical review, and establish competent regulatory frameworks.


Subject(s)
Biomedical Research/ethics , Disease Vectors , Malaria/prevention & control , Malaria/transmission , Mosquito Control/ethics , Mosquito Control/methods , Africa , Animals , Clinical Trials, Phase II as Topic , Clinical Trials, Phase III as Topic , Culicidae/drug effects , Culicidae/growth & development , Culicidae/microbiology , Humans , Pest Control, Biological/ethics , Pest Control, Biological/methods
3.
Vector Borne Zoonotic Dis ; 10(3): 295-311, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19725763

ABSTRACT

Effective vector control, and more specifically mosquito control, is a complex and difficult problem, as illustrated by the continuing prevalence (and spread) of mosquito-transmitted diseases. The sterile insect technique and similar methods control certain agricultural insect pest populations in a species-specific, environmentally sound, and effective manner; there is increased interest in applying this approach to vector control. Such an approach, like all others in use and development, is not a one-size-fits-all solution, and will be more appropriate in some situations than others. In addition, the proposed release of pest insects, and more so genetically modified pest insects, is bound to raise questions in the general public and the scientific community as to such a method's efficacy, safety, and sustainability. This article attempts to address these concerns and indicate where sterile-insect methods are likely to be useful for vector control.


Subject(s)
Culicidae/physiology , Insect Vectors/physiology , Pest Control, Biological/methods , Animals , Female , Humans , Male , Pest Control, Biological/economics , Pest Control, Biological/ethics , Pest Control, Biological/standards
SELECTION OF CITATIONS
SEARCH DETAIL
...